Literature DB >> 15045704

Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells.

A Barbara1, P Delannoy, B G Denis, P J Marie.   

Abstract

There is growing evidence that strontium ranelate (SR; S12911-2, PROTELOS; Institut de Recherches Internationales Servier, Courbevoie, France), a compound containing 2 atoms of stable strontium (Sr), influences bone cells and bone metabolism in vitro and in vivo. We previously reported that SR increases bone mass in rats and mice by stimulating bone formation and inhibiting bone resorption. We also showed that short-term treatment with SR enhances osteoblastic cell recruitment and function in short-term rat calvaria cultures. Because Sr incorporates into the bone matrix, it was of interest to determine whether SR may affect matrix mineralization in long-term culture. To this goal, osteogenic mouse calvaria-derived MC3T3-E1 osteoblastic cells were cultured for up to 14 days in the presence of ascorbic acid and phosphate to induce matrix formation and mineralization. Matrix formation was determined by incorporation of tritiated proline during collagen synthesis. Matrix mineralization was quantified by measuring the number and surface of mineralized nodules using a digital image analyzer. In this model, 1,25(OH)2 vitamin D (1 nmol/L) used as internal control, increased alkaline phosphatase (ALP) activity, an early osteoblast marker, on days 4, 10, and 14 of culture. Treatment with SR (1 mmol/L Sr(2+)) increased ALP activity at days 4 and 14 of culture. SR also increased collagen synthesis at days 4 and 10 of culture. In contrast, 1,25(OH)2 vitamin D (1 nmol/L) inhibited collagen synthesis at 4 to 14 days of culture. Long-term treatment with SR (0.1 to 1 mmol/L Sr(2+)) dose dependently increased Sr concentration into the calcified nodules, but did not alter matrix mineralization in long-term culture, as shown by the ratio of the surface of mineralized nodules to the number of mineralized nodules on day 14 of culture. These results show that long-term treatment with SR increases collagenous matrix formation by MC3T3-E1 osteoblasts without inducing deleterious effect on matrix mineralization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045704     DOI: 10.1016/j.metabol.2003.10.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  44 in total

1.  FOXO1 modulates osteoblast differentiation.

Authors:  Michelle F Siqueira; Stephen Flowers; Rupa Bhattacharya; Dan Faibish; Yugal Behl; Darrell N Kotton; Lou Gerstenfeld; Elizabeth Moran; Dana T Graves
Journal:  Bone       Date:  2011-01-28       Impact factor: 4.398

2.  Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors.

Authors:  Min Pi; L Darryl Quarles
Journal:  J Cell Biochem       Date:  2005-08-15       Impact factor: 4.429

3.  Effects on growth and osteogenic differentiation of mesenchymal stem cells by the strontium-added sol-gel hydroxyapatite gel materials.

Authors:  Maria Grazia Raucci; Daniela Giugliano; M A Alvarez-Perez; Luigi Ambrosio
Journal:  J Mater Sci Mater Med       Date:  2015-02-04       Impact factor: 3.896

Review 4.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

5.  Determination of reference concentrations of strontium in urine by inductively coupled plasma atomic emission spectrometry.

Authors:  Kan Usuda; Koichi Kono; Satsuki Hayashi; Takashi Kawasaki; Go Mitsui; Takahiro Shibutani; Emi Dote; Kazuya Adachi; Michiko Fujihara; Yukari Shimbo; Wei Sun; Bo Lu; Kazuo Nakasuji
Journal:  Environ Health Prev Med       Date:  2006-01       Impact factor: 3.674

6.  [Research progress in the osteogenetic mechanism of strontium].

Authors:  Ning-Ying Zhong; Li-Ping Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

7.  Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs.

Authors:  Pengde Kang; Xiaowei Xie; Zhen Tan; Jing Yang; Bin Shen; Zongke Zhou; Fuxing Pei
Journal:  J Mater Sci Mater Med       Date:  2015-01-30       Impact factor: 3.896

8.  Strontium-substituted hydroxyapatite stimulates osteogenesis on poly(propylene fumarate) nanocomposite scaffolds.

Authors:  Jingfeng Li; Xifeng Liu; Sungjo Park; A Lee Miller; Andre Terzic; Lichun Lu
Journal:  J Biomed Mater Res A       Date:  2018-11-25       Impact factor: 4.396

Review 9.  Strontium ranelate: a novel mode of action optimizing bone formation and resorption.

Authors:  P J Marie
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

10.  Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.

Authors:  J Collette; O Bruyère; J M Kaufman; R Lorenc; D Felsenberg; T D Spector; M Diaz-Curiel; S Boonen; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.